Suppr超能文献

Multiple sclerosis: possible immunological mechanisms.

作者信息

McFarland H F, Dhib-Jalbut S

机构信息

Neuroimmunology Branch, NINCDS, Bethesda, Maryland 20892.

出版信息

Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 2):S96-105. doi: 10.1016/0090-1229(89)90116-5.

Abstract

Multiple sclerosis is the principal demyelinating disease of the central nervous system. Although the prevalence of the disease is moderately low, averaging about 40 cases per 100,000 people in high risk areas, it is a particularly devastating disease. It primarily affects young adults, is chronic, and has an unpredictable course. Most discouraging, the cause of the disease is not known and an effective treatment has not been identified. Recently, however, research has yielded some important findings concerning the etiology of MS. Much evidence now points to an immunological process as one of the major elements in the disease. It is also likely that an environmental influence, possibly an infectious process, may contribute to the disease. Finally, it is now certain that genetic makeup influences susceptibility to the disease. At present, the strongest evidence is for a polygenic effect, not the effect of a single gene or gene locus. This review will examine some of the possible immunologically mediated disease processes that could be involved in MS, especially those that could account for a role for infectious and genetic factors in the disease.

摘要

相似文献

1
Multiple sclerosis: possible immunological mechanisms.
Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 2):S96-105. doi: 10.1016/0090-1229(89)90116-5.
2
Indictment of the microglia as the villain in multiple sclerosis.
Neurology. 1997 Feb;48(2):464-70. doi: 10.1212/wnl.48.2.464.
3
The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders.
Front Immunol. 2019 Feb 8;10:201. doi: 10.3389/fimmu.2019.00201. eCollection 2019.
4
Multiple sclerosis: immune mechanism and update on current therapies.
Ann Neurol. 1995 May;37 Suppl 1:S87-101. doi: 10.1002/ana.410370710.
5
Multiple sclerosis.
J Clin Invest. 2012 Apr;122(4):1180-8. doi: 10.1172/JCI58649. Epub 2012 Apr 2.
6
T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.
Immunol Res. 1990;9(4):287-97. doi: 10.1007/BF02935528.
7
Studies of autoimmunity in multiple sclerosis.
CRC Crit Rev Clin Neurobiol. 1984;1(1):45-82.
8
9
T-cells in multiple sclerosis.
Results Probl Cell Differ. 2010;51:75-98. doi: 10.1007/400_2009_12.
10
Immunological aspects of demyelinating diseases.
Annu Rev Immunol. 1992;10:153-87. doi: 10.1146/annurev.iy.10.040192.001101.

引用本文的文献

2
Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis.
CNS Drugs. 2002;16(8):563-78. doi: 10.2165/00023210-200216080-00005.
3
Microglial cells qualify as the stimulators of unprimed CD4+ and CD8+ T lymphocytes in the central nervous system.
Clin Exp Immunol. 1994 Nov;98(2):313-8. doi: 10.1111/j.1365-2249.1994.tb06143.x.
4
Clinical experience with platelet-activating factor antagonists. Past, present, and near future.
Clin Rev Allergy. 1994 Winter;12(4):397-417. doi: 10.1007/BF02802302.

本文引用的文献

1
Measles virus nucleotide sequences: detection by hybridization in situ.
Science. 1981 May 8;212(4495):672-5. doi: 10.1126/science.7221554.
3
Oligoclonal banding in MS.
Ann N Y Acad Sci. 1984;436:206-12. doi: 10.1111/j.1749-6632.1984.tb14791.x.
4
Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques.
Ann N Y Acad Sci. 1984;436:11-32. doi: 10.1111/j.1749-6632.1984.tb14773.x.
5
The current status of multiple sclerosis intra-blood-brain-barrier IgG synthesis.
Ann N Y Acad Sci. 1984;436:52-67. doi: 10.1111/j.1749-6632.1984.tb14775.x.
8
10
Astrocytes present myelin basic protein to encephalitogenic T-cell lines.
Nature. 1984;307(5948):273-6. doi: 10.1038/307273a0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验